{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T00:04:57Z","timestamp":1788825897148,"version":"build-2803163510"},"reference-count":52,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,2,1]],"date-time":"2013-02-01T00:00:00Z","timestamp":1359676800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Current Opinion in Pharmacology"],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.1016\/j.coph.2012.10.002","type":"journal-article","created":{"date-parts":[[2012,11,2]],"date-time":"2012-11-02T20:01:11Z","timestamp":1351886471000},"page":"56-64","source":"Crossref","is-referenced-by-count":55,"title":["Conjunctival modifications induced by medical and surgical therapies in patients with glaucoma"],"prefix":"10.1016","volume":"13","author":[{"given":"Leonardo","family":"Mastropasqua","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Agnifili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodolfo","family":"Mastropasqua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Fasanella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.coph.2012.10.002_bib0005","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1001\/archopht.121.1.48","article-title":"Early Manifest Glaucoma Trial Group: factors for glaucoma progression and the effect of treatment: the early manifest glaucoma trial","volume":"121","author":"Leske","year":"2003","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.coph.2012.10.002_bib0010","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1016\/S0161-6420(01)00873-9","article-title":"Interim clinical outcomes in the Collaborative Initial Glaucoma Treatment Study comparing initial treatment randomized to medications or surgery","volume":"108","author":"Lichter","year":"2001","journal-title":"Ophthalmology"},{"key":"10.1016\/j.coph.2012.10.002_bib0015","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1177\/112067210801800314","article-title":"An in vivo confocal microscopy and impression cytology analysis of preserved and unpreserved levobunolol-induced conjunctival changes","volume":"18","author":"Ciancaglini","year":"2008","journal-title":"Eur J Ophthalmol"},{"issue":"Suppl 1","key":"10.1016\/j.coph.2012.10.002_bib0020","doi-asserted-by":"crossref","first-page":"S93","DOI":"10.1016\/j.survophthal.2008.08.004","article-title":"Side effects associated with prostaglandin analog therapy","volume":"53","author":"Alm","year":"2008","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.coph.2012.10.002_bib0025","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1007\/s00417-012-1943-6","article-title":"Effects of long-term topical anti-glaucoma medications on meibomian glands","volume":"250","author":"Arita","year":"2012","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.coph.2012.10.002_bib0030","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1001\/archopht.1994.01090230060021","article-title":"Adverse effects of topical antiglaucoma medication. II. The outcome of filtration surgery","volume":"112","author":"Broadway","year":"1994","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.coph.2012.10.002_bib0035","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/1477-7525-1-75","article-title":"Vision-related quality of life and topical glaucoma treatment side-effects","volume":"10","author":"Nordmann","year":"2003","journal-title":"Health Qual Life Outcomes"},{"key":"10.1016\/j.coph.2012.10.002_bib0040","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1097\/IJG.0b013e318181283e","article-title":"Needle revision of filtering blebs","volume":"17","author":"Feldman","year":"2008","journal-title":"J Glaucoma"},{"key":"10.1016\/j.coph.2012.10.002_bib0045_1","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.preteyeres.2009.06.004","article-title":"The critical role of the conjunctiva in glaucoma filtration surgery","volume":"28","author":"Yu","year":"2009","journal-title":"Prog Retin Eye Res"},{"key":"10.1016\/j.coph.2012.10.002_bib0050","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1016\/j.ophtha.2007.03.050","article-title":"A phase III study of subconjunctival human anti-transforming growth factor beta(2) monoclonal antibody (CAT-152) to prevent scarring after first-time trabeculectomy","volume":"114","author":"Khaw","year":"2007","journal-title":"Ophthalmology"},{"key":"10.1016\/j.coph.2012.10.002_bib0055","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1136\/bjo.2009.163170","article-title":"Canaloplasty for primary open-angle glaucoma: long-term outcome","volume":"94","author":"Grieshaber","year":"2010","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.coph.2012.10.002_bib0060","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s00417-011-1778-6","article-title":"Histological findings of failed gold micro shunts in primary open angle glaucoma","volume":"250","author":"Agnifili","year":"2012","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.coph.2012.10.002_bib0065","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1016\/j.ajo.2011.12.017","article-title":"Second generation trabecular meshwork bypass stent (iStent inject) increases outflow facility in cultured human anterior segments","volume":"153","author":"Bahler","year":"2012","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.coph.2012.10.002_bib0070","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1136\/bjo.2008.152496","article-title":"Conjunctival characteristics in primary open angle glaucoma and modifications induced by trabeculectomy with mitomycin C: an in vivo confocal microscopy study","volume":"93","author":"Ciancaglini","year":"2009","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.coph.2012.10.002_bib0075","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1136\/bjo.2010.179994","article-title":"In vivo analysis of conjunctiva in gold micro shunt implantation for glaucoma","volume":"94","author":"Mastropasqua","year":"2010","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.coph.2012.10.002_bib0080_1","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1136\/bjophthalmol-2011-301058","article-title":"In vivo analysis of conjunctiva in canaloplasty for glaucoma","volume":"96","author":"Mastropasqua","year":"2012","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.coph.2012.10.002_bib0085","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1111\/j.1755-3768.2008.01250.x","article-title":"Detrimental effect of preservatives in eyedrops: implications for the treatment of glaucoma","volume":"86","author":"Baudouin","year":"2008","journal-title":"Acta Ophthalmol"},{"key":"10.1016\/j.coph.2012.10.002_bib0090_1","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.preteyeres.2010.03.001","article-title":"Preservatives in eye drops: the good, the bad and the ugly","volume":"29","author":"Baudouin","year":"2010","journal-title":"Prog Ret Eye Res"},{"key":"10.1016\/j.coph.2012.10.002_bib0095","first-page":"619","article-title":"Effects of benzalkonium chloride on growth and survival of Chang conjunctival cells","volume":"40","author":"De Saint Jean","year":"1999","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.coph.2012.10.002_bib0100","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S1542-0124(11)70025-8","article-title":"Benzalkonium chloride in glaucoma medications","volume":"9","author":"Noecker","year":"2011","journal-title":"Ocul Surf"},{"key":"10.1016\/j.coph.2012.10.002_bib0105","series-title":"The Preocular Tear Film","article-title":"Effect of ophthalmic preservatives on the ocular surface: conjunctival and corneal uptake and distribution of benzalkonium chloride and chlorhexidine digluconate","author":"Champeau","year":"1986"},{"key":"10.1016\/j.coph.2012.10.002_bib0110","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1007\/BF02850204","article-title":"The dilution of benzalkonium chloride (BAK) in the tear film","volume":"23","author":"Friedlaender","year":"2006","journal-title":"Adv Ther"},{"key":"10.1016\/j.coph.2012.10.002_bib0115","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.ophtha.2007.01.036","article-title":"The ocular surface of glaucoma patients treated over the long term expresses inflammatory markers related to both T-helper 1 and T-helper 2 pathways","volume":"115","author":"Baudouin","year":"2008","journal-title":"Ophthalmology"},{"key":"10.1016\/j.coph.2012.10.002_bib0120","doi-asserted-by":"crossref","first-page":"5473","DOI":"10.1167\/iovs.06-0728","article-title":"New tools for the evaluation of toxic ocular surface changes in the rat","volume":"48","author":"Pauly","year":"2007","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.coph.2012.10.002_bib0125","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1097\/01.ico.0000116526.57227.82","article-title":"Corneal and conjunctival changes caused by commonly used glaucoma medications","volume":"23","author":"Noecker","year":"2004","journal-title":"Cornea"},{"key":"10.1016\/j.coph.2012.10.002_bib0130","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1097\/ICO.0b013e31815cf651","article-title":"Comparison of corneal and conjunctival changes after dosing of travoprost preserved with sofZia, latanoprost with 0.02% benzalkonium chloride, and preservative-free artificial tears","volume":"27","author":"Kahook","year":"2008","journal-title":"Cornea"},{"key":"10.1016\/j.coph.2012.10.002_bib0135_1","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1007\/s12325-010-0070-1","article-title":"Effects of benzalkonium chloride preserved, polyquad-preserved, and sofZia-preserved topical glaucoma medications on human ocular epithelial cells","volume":"27","author":"Ammar","year":"2010","journal-title":"Adv Ther"},{"key":"10.1016\/j.coph.2012.10.002_bib0140","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1016\/j.ophtha.2004.06.023","article-title":"Conjunctival epithelial cell expression of interleukins and inflammatory markers in glaucoma patients treated over the long term","volume":"111","author":"Baudouin","year":"2004","journal-title":"Ophthalmology"},{"key":"10.1016\/j.coph.2012.10.002_bib0145","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/108076802317233162","article-title":"HLA-DR expression in conjunctival cells after latanoprost","volume":"18","author":"Guglielminetti","year":"2002","journal-title":"J Ocul Pharmacol Ther"},{"key":"10.1016\/j.coph.2012.10.002_bib0150","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1007\/s12325-008-0078-y","article-title":"Quantitative analysis of conjunctival goblet cells after chronic application of topical drops","volume":"25","author":"Kahook","year":"2008","journal-title":"Adv Ther"},{"key":"10.1016\/j.coph.2012.10.002_bib0155","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1136\/bjo.2008.138768","article-title":"Conjunctival and corneal reactions in rabbits following short- and repeated exposure to preservative-free tafluprost, commercially available latanoprost and 0.02% benzalkonium chloride","volume":"92","author":"Liang","year":"2008","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.coph.2012.10.002_bib0160","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1167\/iovs.03-1067","article-title":"Conjunctival proinflammatory and proapoptotic effects of latanoprost and preserved and unpreserved timolol: an ex vivo and in vitro study","volume":"45","author":"Pisella","year":"2004","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.coph.2012.10.002_bib0165","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/S1542-0124(11)70024-6","article-title":"Preservative use in topical glaucoma medications","volume":"9","author":"Tressler","year":"2011","journal-title":"Ocul Surf"},{"key":"10.1016\/j.coph.2012.10.002_bib0170","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1007\/BF00166608","article-title":"Conjunctiva and subconjunctival tissue in primary open-angle glaucoma after long-term topical treatment: an immunohistochemical and ultrastructural study","volume":"233","author":"Nuzzi","year":"1995","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.coph.2012.10.002_bib0175","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.ajo.2006.02.056","article-title":"Effects of topical antiglaucoma application on conjunctival impression cytology specimens","volume":"142","author":"Hong","year":"2006","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.coph.2012.10.002_bib0180","doi-asserted-by":"crossref","first-page":"9116","DOI":"10.1167\/iovs.11-7988","article-title":"Ocular surface epithelial thickness evaluation with Spectral-Domain Optical Coherence Tomography","volume":"52","author":"Francoz","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.coph.2012.10.002_bib0185","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1046\/j.1442-9071.2003.00760.x","article-title":"Effects of topical antiglaucoma drugs on apoptosis rates of conjunctival epithelial cells in glaucoma patients","volume":"32","author":"Do\u011fan","year":"2004","journal-title":"Clin Exp Ophthalmol"},{"key":"10.1016\/j.coph.2012.10.002_bib0190","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S0161-6420(89)32888-0","article-title":"Long-term morphologic effects of antiglaucoma drugs on the conjunctiva and Tenon's capsule in glaucomatous patients","volume":"96","author":"Sherwood","year":"1989","journal-title":"Ophthalmology"},{"key":"10.1016\/j.coph.2012.10.002_bib0195","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1097\/01.ijg.0000212274.50229.c6","article-title":"Travoprost 0.004% with and without benzalkonium chloride: a comparison of safety and efficacy","volume":"16","author":"Lewis","year":"2007","journal-title":"J Glaucoma"},{"key":"10.1016\/j.coph.2012.10.002_bib0200","series-title":"The Lacrimal System","article-title":"The effect of different benzalkonium chloride concentrations on human normal ocular surface","author":"Rolando","year":"2004"},{"key":"10.1016\/j.coph.2012.10.002_bib0205","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1590\/S0004-27492007000600005","article-title":"Conjunctival changes induced by prostaglandin analogues and timolol maleate: a histomorphometric study","volume":"70","author":"Russ","year":"2007","journal-title":"Arq Bras Oftalmol"},{"key":"10.1016\/j.coph.2012.10.002_bib0210","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/S0161-6420(94)31322-4","article-title":"Expression of inflammatory membrane markers by conjunctival cells in chronically treated patients with glaucoma","volume":"101","author":"Baudouin","year":"1994","journal-title":"Ophthalmology"},{"key":"10.1016\/j.coph.2012.10.002_bib0215","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/S0161-6420(99)90116-1","article-title":"Ocular surface inflammatory changes induced by topical antiglaucoma drugs: human and animal studies","volume":"106","author":"Baudouin","year":"1999","journal-title":"Ophthalmology"},{"key":"10.1016\/j.coph.2012.10.002_bib0220","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1097\/IJG.0b013e3181132188","article-title":"Brimonidine-induced anterior uveitis and conjunctivitis clinical and histologic features","volume":"17","author":"Nguyen","year":"2008","journal-title":"J Glaucoma"},{"key":"10.1016\/j.coph.2012.10.002_bib0225","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.ajo.2004.03.006","article-title":"Conjunctival hyperemia associated with bimatoprost use: a histopathologic study","volume":"138","author":"Leal","year":"2004","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.coph.2012.10.002_bib0230","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ajo.2011.05.033","article-title":"Ocular surface disease and quality of life in patients with glaucoma","volume":"153","author":"Skalicky","year":"2012","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.coph.2012.10.002_bib0235","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1111\/j.1442-9071.2009.02023.x","article-title":"Histopathology of a functioning mitomycin-C trabeculectomy","volume":"37","author":"Liang","year":"2009","journal-title":"Clin and Exp Ophthalmol"},{"key":"10.1016\/j.coph.2012.10.002_bib0240","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1016\/j.ophtha.2007.10.024","article-title":"Filtering blebs and aqueous pathway. An immunocytological and in vivo confocal microscopy","volume":"115","author":"Amar","year":"2008","journal-title":"Ophthalmology"},{"key":"10.1016\/j.coph.2012.10.002_bib0245","first-page":"714","article-title":"Bleb morphology and histology in a rabbit model of glaucoma filtration surgery using Ozurdex\u00ae or mitomycin-C","volume":"18","author":"SooHoo","year":"2012","journal-title":"Mol Vis"},{"key":"10.1016\/j.coph.2012.10.002_bib0250","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/ddr.430220102","article-title":"Growth factors in the aqueous humor and their therapeutic implications in glaucoma and anterior segment disorders of the human eye","volume":"22","author":"Tripathi","year":"2004","journal-title":"Drug Dev Res"},{"key":"10.1016\/j.coph.2012.10.002_bib0255_1","doi-asserted-by":"crossref","first-page":"3042","DOI":"10.1167\/iovs.07-1201","article-title":"Conjunctival modifications in ocular hypertension and primary open angle glaucoma: an in vivo confocal microscopy study","volume":"49","author":"Ciancaglini","year":"2008","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.coph.2012.10.002_bib0260","article-title":"Conjunctival findings in hyperbaric and low-tension glaucoma: an in vivo confocal microscopy study","author":"Agnifili","year":"2011","journal-title":"Acta Ophthalmol"}],"container-title":["Current Opinion in Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471489212001981?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471489212001981?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,5]],"date-time":"2019-07-05T06:02:52Z","timestamp":1562306572000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1471489212001981"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2]]},"references-count":52,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,2]]}},"alternative-id":["S1471489212001981"],"URL":"https:\/\/doi.org\/10.1016\/j.coph.2012.10.002","relation":{},"ISSN":["1471-4892"],"issn-type":[{"value":"1471-4892","type":"print"}],"subject":[],"published":{"date-parts":[[2013,2]]}}}